ICON Ups China Presence and Posits Double-Standard in China Trials
March 29, 2011 at 12:11 PM EDT
ICON plc,, the global clinical-stage CRO based in Ireland, is adding to its China facilities, opening a new office in Shanghai and increasing the space of its Beijing operation. Separately, ICON said a double standard exists in China clinical trials, with different levels of quality separating trials for multinationals from those conducted for local products. More details.... Stock Symbol: (NSDQ: ICLR) Share this with colleagues: var switchTo5x=true; stLight.options({publisher:'d7871f5b-67bc-4d30-b66f-1465d0b97213'});